• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Macerich Company filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    5/12/25 7:00:30 AM ET
    $MAC
    Real Estate Investment Trusts
    Real Estate
    Get the next $MAC alert in real time by email
    mac-20250512
    0000912242FALSE00009122422025-05-122025-05-12

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): May 12, 2025

    THE MACERICH COMPANY
    (Exact name of registrant as specified in its charter)

    Maryland1-1250495-4448705
    (State or other jurisdiction
    of incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)

    401 Wilshire Boulevard, Suite 700, Santa Monica, California 90401
    (Address of principal executive offices) (Zip code)

    Registrant’s telephone number, including area code (310) 394-6000

    N/A
    (Former name or former address, if changed since last report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

    Title of each class
    Trading symbol(s)
    Name of each exchange on which registered
    Common stock of The Macerich Company, $0.01 par value per shareMACThe New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

    Emerging growth company    ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    ITEM 2.02    RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

    On May 12, 2025, The Macerich Company (the “Company”) released its financial results for the three months ended March 31, 2025 by posting to its website a financial supplement containing financial and operating information of the Company (“Earnings Results & Supplemental Information”) and such Earnings Results & Supplemental Information is furnished as Exhibit 99.1 hereto.

    The Earnings Results & Supplemental Information included as an exhibit with this report is being furnished pursuant to Item 2.02 of Form 8-K and shall not be deemed to be “filed” with the SEC or incorporated by reference into any other filing with the SEC.

    ITEM 7.01    REGULATION FD DISCLOSURE.

    The Earnings Results & Supplemental Information included as an exhibit with this report is being furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed to be “filed” with the SEC or incorporated by reference into any other filing with the SEC.

    ITEM 9.01    FINANCIAL STATEMENTS AND EXHIBITS.

    Listed below are the financial statements, pro forma financial information and exhibits furnished as part of this report:

    (a), (b) and (c) Not applicable.

    (d) Exhibit.

    Exhibit Index attached hereto and incorporated herein by reference.

    2





    EXHIBIT INDEX



    EXHIBIT
    NUMBER
    NAME
    99.1
    Earnings Results & Supplemental Information for the Three Months Ended March 31, 2025
    104Cover Page Interactive Data File (embedded within the Inline XBRL document)
    3





    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, The Macerich Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    THE MACERICH COMPANY
    By: Daniel Swanstrom
    May 12, 2025
    /s/ Daniel Swanstrom
    DateSenior Executive Vice President,
    Chief Financial Officer
    and Treasurer
    4




    Get the next $MAC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MAC

    DatePrice TargetRatingAnalyst
    6/10/2025$18.00Neutral → Outperform
    Mizuho
    5/23/2025$16.00Underweight → Neutral
    Piper Sandler
    4/10/2025Hold → Buy
    Truist
    1/15/2025$20.00Underweight → Equal-Weight
    Morgan Stanley
    1/2/2025$19.00 → $23.00Hold → Buy
    Jefferies
    12/17/2024$22.00Hold
    Deutsche Bank
    12/17/2024$22.00Sector Underperform → Sector Perform
    Scotiabank
    12/4/2024$14.00 → $22.00Underperform → Neutral
    Mizuho
    More analyst ratings